Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2012

01-10-2012 | Basic Science

Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells

Authors: Juan Ye, Huina Zhang, Han Wu, Changjun Wang, Xin Shi, Jiajun Xie, Jinjing He, Jun Yang

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2012

Login to get access

Abstract

Background

To investigate genotoxicity of the preservative thimerosal (Thi), and the cytoprotective and antioxidant effects of hyaluronic Acid (HA) and hydroxypropyl methylcellulose (HPMC) on Chang conjunctival cells.

Method

Cells were divided into three groups. One group was exposed to Thi at various concentrations (0.00001 %∼0.001 %) for 30 min; the other two groups were pretreated with 0.3 % HA or 0.3 % HPMC for 30 min before the Thi exposure. After cell viability was evaluated, alkaline comet assay and detection of the phosphorylated form of the histone variant H2AX (γH2AX) foci were used to determine DNA damage. Reactive oxygen species (ROS) production was assessed by the fluorescent probe, 2', 7'-dichlorodihydrofluorescein diacetate (DCFH-DA).

Results

A significant change of cell viability was observed after exposure to 0.001 % Thi for 30 min. DNA single- and double-strand breaks were significantly increased in a dose-dependent manner with Thi exposure. In addition, intracellular ROS induced by Thi was dose-dependent, except at 0.001 % less ROS was induced than at 0.0005 %. However, cells pretreated with 0.3 % HA or 0.3 % HPMC showed significantly increased cell survival, decreased DNA damage, and decreased ROS production compared to cells exposed to Thi alone. Pretreatment with 0.3 % HA was found to be even more protective than 0.3 % HPMC.

Conclusion

Thi can induce DNA damage in human conjunctival epithelial cells, probably due to oxidative stress. HA and HPMC are protective agents that have antioxidant properties and can decrease DNA damage induced by Thi. Pretreatment of 0.3 % HA may be more protective of the ocular surface than 0.3 % HPMC.
Literature
1.
go back to reference Van Horn DL, Edelhauser HF, Prodanovich G, Eiferman R, Pederson HF (1977) Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci 16:273–280PubMed Van Horn DL, Edelhauser HF, Prodanovich G, Eiferman R, Pederson HF (1977) Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci 16:273–280PubMed
2.
go back to reference Mondino BJ, Groden LR (1980) Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol 98:1767–1770PubMedCrossRef Mondino BJ, Groden LR (1980) Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol 98:1767–1770PubMedCrossRef
3.
go back to reference Ferrat L, Romeo M, Gnassia-Barelli M, Pergent-Martini C (2002) Effects of mercury on antioxidant mechanisms in the marine phanerogam Posidonia oceanica. Dis Aquat Organ 50:157–160PubMedCrossRef Ferrat L, Romeo M, Gnassia-Barelli M, Pergent-Martini C (2002) Effects of mercury on antioxidant mechanisms in the marine phanerogam Posidonia oceanica. Dis Aquat Organ 50:157–160PubMedCrossRef
4.
go back to reference Ben-Ozer EY, Rosenspire AJ, McCabe MJ Jr, Worth RG, Kindzelskii AL, Warra NS, Petty HR (2000) Mercuric chloride damages cellular DNA by a non-apoptotic mechanism. Mutat Res 470:19–27PubMedCrossRef Ben-Ozer EY, Rosenspire AJ, McCabe MJ Jr, Worth RG, Kindzelskii AL, Warra NS, Petty HR (2000) Mercuric chloride damages cellular DNA by a non-apoptotic mechanism. Mutat Res 470:19–27PubMedCrossRef
5.
go back to reference Morgan SE, Kastan MB (1997) p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res 71:1–25PubMedCrossRef Morgan SE, Kastan MB (1997) p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res 71:1–25PubMedCrossRef
6.
go back to reference Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371–386PubMed Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371–386PubMed
7.
go back to reference Aragona P, Di SG, Ferreri F, Spinella R, Stilo A (2002) Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br J Ophthalmol 86:879–884PubMedCrossRef Aragona P, Di SG, Ferreri F, Spinella R, Stilo A (2002) Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br J Ophthalmol 86:879–884PubMedCrossRef
8.
go back to reference Aragona P, Papa V, Micali A, Santocono M, Milazzo G (2002) Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181–184PubMedCrossRef Aragona P, Papa V, Micali A, Santocono M, Milazzo G (2002) Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181–184PubMedCrossRef
9.
go back to reference Johnson ME, Murphy PJ, Boulton M (2006) Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol 244:109–112PubMedCrossRef Johnson ME, Murphy PJ, Boulton M (2006) Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol 244:109–112PubMedCrossRef
10.
go back to reference Toda I, Shinozaki N, Tsubota K (1996) Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome. Cornea 15:120–128PubMedCrossRef Toda I, Shinozaki N, Tsubota K (1996) Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome. Cornea 15:120–128PubMedCrossRef
11.
go back to reference Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–1135PubMedCrossRef Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–1135PubMedCrossRef
12.
go back to reference Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191PubMedCrossRef Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191PubMedCrossRef
13.
go back to reference Zhou C, Li Z, Diao H, Yu Y, Zhu W, Dai Y, Chen FF, Yang J (2006) DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors. Mutat Res 604:8–18PubMedCrossRef Zhou C, Li Z, Diao H, Yu Y, Zhu W, Dai Y, Chen FF, Yang J (2006) DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors. Mutat Res 604:8–18PubMedCrossRef
14.
go back to reference Sasaki H, Igarashi Y, Nagano T, Nishida K, Nakamura J (1995) Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm Res 12:1146–1150PubMedCrossRef Sasaki H, Igarashi Y, Nagano T, Nishida K, Nakamura J (1995) Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm Res 12:1146–1150PubMedCrossRef
15.
go back to reference Kumaravel TS, Jha AN (2006) Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res 605:7–16PubMedCrossRef Kumaravel TS, Jha AN (2006) Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res 605:7–16PubMedCrossRef
16.
go back to reference Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W (2002) Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12:162–169PubMedCrossRef Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W (2002) Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12:162–169PubMedCrossRef
17.
go back to reference Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3:959–967CrossRef Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3:959–967CrossRef
18.
go back to reference Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM (2002) Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 158:486–492PubMedCrossRef Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM (2002) Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 158:486–492PubMedCrossRef
19.
go back to reference Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR (1992) Microbial contamination of in-use ocular medications. Arch Ophthalmol 110:82–85PubMedCrossRef Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR (1992) Microbial contamination of in-use ocular medications. Arch Ophthalmol 110:82–85PubMedCrossRef
20.
go back to reference Fuerst DJ, Sugar J, Worobec S (1983) Superior limbic keratoconjunctivitis associated with cosmetic soft contact lens wear. Arch Ophthalmol 101:1214–1216PubMedCrossRef Fuerst DJ, Sugar J, Worobec S (1983) Superior limbic keratoconjunctivitis associated with cosmetic soft contact lens wear. Arch Ophthalmol 101:1214–1216PubMedCrossRef
21.
go back to reference Whittington CV (1985) Elicitation of contact lens allergy to thimerosal by eye cream. Contact Dermatitis 13:186PubMedCrossRef Whittington CV (1985) Elicitation of contact lens allergy to thimerosal by eye cream. Contact Dermatitis 13:186PubMedCrossRef
22.
go back to reference Zadnik K (1984) Severe allergic reaction to saline preserved with thimerosal. J Am Optom Assoc 55:507–509PubMed Zadnik K (1984) Severe allergic reaction to saline preserved with thimerosal. J Am Optom Assoc 55:507–509PubMed
23.
go back to reference Coward BD, Neumann R, Callender M (1984) Solution intolerance among users of four chemical soft lens care regimens. Am J Optom Physiol Opt 61:523–527PubMedCrossRef Coward BD, Neumann R, Callender M (1984) Solution intolerance among users of four chemical soft lens care regimens. Am J Optom Physiol Opt 61:523–527PubMedCrossRef
24.
go back to reference Mondino BJ, Brawman-Mintzer O, Boothe WA (1987) Immunological complications of soft contact lenses. J Am Optom Assoc 58:832–835PubMed Mondino BJ, Brawman-Mintzer O, Boothe WA (1987) Immunological complications of soft contact lenses. J Am Optom Assoc 58:832–835PubMed
25.
go back to reference Wilson LA, McNatt J, Reitschel R (1981) Delayed hypersensitivity to thimerosal in soft contact lens wearers. Ophthalmology 88:804–809PubMed Wilson LA, McNatt J, Reitschel R (1981) Delayed hypersensitivity to thimerosal in soft contact lens wearers. Ophthalmology 88:804–809PubMed
26.
go back to reference Shulman IA, Hasz LA, Simpson RB (1982) Thimerosal dependent agglutination, a newly described blood bank problem. Transfusion 22:241–243PubMedCrossRef Shulman IA, Hasz LA, Simpson RB (1982) Thimerosal dependent agglutination, a newly described blood bank problem. Transfusion 22:241–243PubMedCrossRef
27.
go back to reference Shulman IA, Simpson RB, Farmer CF, Lam HT (1984) Thimerosal-dependent agglutination complicating the serologic evaluation for unexpected antibodies. Transfusion 24:365–367PubMedCrossRef Shulman IA, Simpson RB, Farmer CF, Lam HT (1984) Thimerosal-dependent agglutination complicating the serologic evaluation for unexpected antibodies. Transfusion 24:365–367PubMedCrossRef
28.
go back to reference Shenker BJ, Guo TL, O I, Shapiro IM (1999) Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 157:23-35 Shenker BJ, Guo TL, O I, Shapiro IM (1999) Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 157:23-35
29.
go back to reference Ariza ME, Holliday J, Williams MV (1994) Mutagenic effect of mercury (II) in eukaryotic cells. In Vivo 8:559–563PubMed Ariza ME, Holliday J, Williams MV (1994) Mutagenic effect of mercury (II) in eukaryotic cells. In Vivo 8:559–563PubMed
30.
go back to reference Hamilton-Koch W, Snyder RD, Lavelle JM (1986) Metal-induced DNA damage and repair in human diploid fibroblasts and Chinese hamster ovary cells. Chem Biol Interact 59:17–28PubMedCrossRef Hamilton-Koch W, Snyder RD, Lavelle JM (1986) Metal-induced DNA damage and repair in human diploid fibroblasts and Chinese hamster ovary cells. Chem Biol Interact 59:17–28PubMedCrossRef
31.
go back to reference McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A (1993) The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47–63PubMedCrossRef McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A (1993) The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47–63PubMedCrossRef
32.
go back to reference Fernandez-Capetillo O, Celeste A, Nussenzweig A (2003) Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2:426–427PubMedCrossRef Fernandez-Capetillo O, Celeste A, Nussenzweig A (2003) Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2:426–427PubMedCrossRef
33.
go back to reference Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4:993–997PubMedCrossRef Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4:993–997PubMedCrossRef
34.
go back to reference Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (2004) Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 52:794–804PubMed Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (2004) Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 52:794–804PubMed
35.
go back to reference Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef
36.
go back to reference Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609–662PubMedCrossRef Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609–662PubMedCrossRef
37.
go back to reference Migdal C, Foggia L, Tailhardat M, Courtellemont P, Haftek M, Serres M (2010) Sensitization effect of thimerosal is mediated in vitro via reactive oxygen species and calcium signaling. Toxicology 274:1–9PubMedCrossRef Migdal C, Foggia L, Tailhardat M, Courtellemont P, Haftek M, Serres M (2010) Sensitization effect of thimerosal is mediated in vitro via reactive oxygen species and calcium signaling. Toxicology 274:1–9PubMedCrossRef
38.
go back to reference Barzilai A, Yamamoto K (2004) DNA damage responses to oxidative stress. DNA Repair (Amst) 3:1109–1115CrossRef Barzilai A, Yamamoto K (2004) DNA damage responses to oxidative stress. DNA Repair (Amst) 3:1109–1115CrossRef
39.
go back to reference Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C (2000) Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res 32:3–8PubMedCrossRef Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C (2000) Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res 32:3–8PubMedCrossRef
40.
go back to reference Kim SW, Bae YH, Okano T (1992) Hydrogels: swelling, drug loading, and release. Pharm Res 9:283–290PubMedCrossRef Kim SW, Bae YH, Okano T (1992) Hydrogels: swelling, drug loading, and release. Pharm Res 9:283–290PubMedCrossRef
41.
go back to reference Leibowitz HM, Chang RK, Mandell AI (1984) Gel tears. A new medication for the treatment of dry eyes. Ophthalmology 91:1199–1204PubMed Leibowitz HM, Chang RK, Mandell AI (1984) Gel tears. A new medication for the treatment of dry eyes. Ophthalmology 91:1199–1204PubMed
42.
go back to reference Pape LG, Balazs EA (1980) The use of sodium hyaluronate (Healon) in human anterior segment surgery. Ophthalmology 87:699–705PubMed Pape LG, Balazs EA (1980) The use of sodium hyaluronate (Healon) in human anterior segment surgery. Ophthalmology 87:699–705PubMed
43.
go back to reference DeLuise VP, Peterson WS (1984) The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol 16:823–824PubMed DeLuise VP, Peterson WS (1984) The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol 16:823–824PubMed
44.
go back to reference Stuart JC, Linn JG (1985) Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol 17:190–192PubMed Stuart JC, Linn JG (1985) Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol 17:190–192PubMed
45.
go back to reference Gill GW, Frost JK, Miller KA (1974) A new formula for a half-oxidized hematoxylin solution that neither overstains nor requires differentiation. Acta Cytol 18:300–311PubMed Gill GW, Frost JK, Miller KA (1974) A new formula for a half-oxidized hematoxylin solution that neither overstains nor requires differentiation. Acta Cytol 18:300–311PubMed
46.
go back to reference Papa V, Aragona P, Russo S, Di BA, Russo P, Milazzo G (2001) Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients. Ophthalmologica 215:124–127PubMedCrossRef Papa V, Aragona P, Russo S, Di BA, Russo P, Milazzo G (2001) Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients. Ophthalmologica 215:124–127PubMedCrossRef
47.
go back to reference Pauloin T, Dutot M, Warnet JM, Rat P (2008) In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 34:263–273PubMedCrossRef Pauloin T, Dutot M, Warnet JM, Rat P (2008) In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 34:263–273PubMedCrossRef
48.
go back to reference Augustin AJ, Dick HB (2004) Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg 30:424–427PubMedCrossRef Augustin AJ, Dick HB (2004) Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg 30:424–427PubMedCrossRef
Metadata
Title
Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells
Authors
Juan Ye
Huina Zhang
Han Wu
Changjun Wang
Xin Shi
Jiajun Xie
Jinjing He
Jun Yang
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2012
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-2087-4

Other articles of this Issue 10/2012

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2012 Go to the issue